Published by IQ4I on 3rd March 2017 | Ref: 1005249 | This Report Is In Stock
Interventional cardiology specifically deals with the catheter based treatment of cardiovascular and structural heart diseases. Products of interventional cardiology market are Catheters, Interventional Diagnostic Catheters, stents, valves, transcatheter heart pump and others. Catheters are segmented into Guide Catheter, Balloon Catheter, Atherectomy Catheters, Thrombectomy Catheters, and Ablation Catheters. Interventional Diagnostic Catheters are segmented into Intravascular ultrasound (IVUS), Fractional flow reserve (FFR), Optical coherence tomography (OCT), Angiograph, Pulmonary artery catheter, Electrophysiology catheter. Stents are further categorised into bare metal stents, drug eluting stents, Bioresorbable stents and Stent grafts. Valves are further divided into Transcatheter Aortic Valve, Annuloplasty Ring, Mitral Clip, and Valvuloplasty. Others are segmented into closure devices (Occluders), Inferior vena cava filters, Guide wires, Transcatheter pacemaker, and accessories.
Applications of Interventional cardiology market are segmented into Diagnostic catheterization, Coronary Interventions, Peripheral interventions and Structural Heart. Coronary intervention application is sub-segmented into Aortic aneurysm (EAVR, TEVAR), Coronary Thrombectomy, PCTA, Coronary Cardiac Ablation and others. Peripheral interventions are sub-segmented into Peripheral Aneurysm, Peripheral Thrombectomy, Peripheral Angioplasty, Peripheral Ablation, Pulmonary embolism, and others. Structural heart is further sub-segmented into Valve replacement, Valve repair, Heart Assist Device, Congenital heart defect and others.
The interventional cardiology global market is expected to grow at a CAGR of high single digit CAGR to reach ,124.1 million by 2023. Among the Interventional cardiology products, the stents market dominated the products market by occupying a largest share. At the same time, Transcatheter heart pump market is the fastest growing segment projected to grow at a high double digit CAGR. In applications, Coronary Interventions is the largest segment and Structural Heart is the fastest growing segment with the strong CAGR.
Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is projected to be the fastest growing region suggesting an opportunities for growth and likely to get attention of new investors in the interventional cardiology market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.
Increasing incidences of cardiovascular diseases due to change in lifestyle, Demand for minimally invasive treatment due to less complication, Rise in the number of Cardiovascular disorders and ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the Interventional cardiology global market. Many entry level barriers, stringent regulation and lack of skilled and trained professionals are some of the factors hampering the growth of Interventional cardiology market.
The interventional cardiology global market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the interventional cardiology market are Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Johnson & Johnson (U.S.).
1 EXECUTIVE SUMMARY 32
2 INTRODUCTION 37
2.1 KEY TAKEAWAYS 37
2.2 REPORT DESCRIPTION 38
2.3 MARKETS COVERED 40
2.4 STAKEHOLDERS 42
2.5 RESEARCH METHODOLOGY 42
3 MARKET ANALYSIS 51
3.1 INTRODUCTION 51
3.2 MARKET SEGMENTATION 52
3.3 FACTORS INFLUENCING MARKET 54
in aging population 55
3.4 REGULATORY AFFAIRS 64
3.5 REIMBURSEMENT SCENARIO 69
3.6 CLINICL TRIAL DATA 101
3.7 PATENT TRENDS 114
3.8 TECHNOLOGICAL ADVANCEMENTS 116
3.9 PORTER’S FIVE FORCE ANALYSIS 118
3.10 PEDIATRIC INTERVENTIONAL CARDIOLOGY 122
3.11 SUPPLY CHAIN ANALYSIS 123
3.12 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 128
4 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET, BY PRODUCT 131
4.1 INTRODUCTION 131
4.2 CATHETERS 134
4.3 INTERVENTIOAL DIAGNOSTIC CATHETERS 153
4.4 STENTS 170
4.5 VALVES 186
4.6 TRANSCATHETER HEART PUMP 200
4.7 OTHERS 203
5 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET, BY APPLICATION 213
5.1 INTRODUCTION 213
5.2 DIAGNOSTIC CATHETERIZATION 216
5.3 CORONARY INTERVENTIONS 218
5.4 PERIPHERAL INTERVENTIONS 233
5.5 STRUCTURAL HEART 248
6 REGIONAL ANALYSIS 263
6.1 INTRODUCTION 263
6.2 NORTH AMERICA 266
6.3 EUROPE 291
6.4 APAC 326
6.5 ROW 361
7 COMPANY DEVELOPMENTS 390
7.1 INTRODUCTION 390
7.2 APPROVALS 391
7.3 ACQUISITIONS AND MERGERS 405
7.4 NEW PRODUCT LAUNCH 409
7.5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS AND JOINT VENTURES 411
7.6 OTHER DEVELOPMENTS 413
8 MAJOR COMPANIES 414
8.1 ABBOTT LABORATORIES 414
8.2 ABIOMED 423
8.3 B.BRAUN MELSUNGEN AG 431
8.4 BOSTON SCIENTIFIC CORPOARTION 439
8.5 C.R.BARD INC. 453
8.6 COOK MEDICAL, INC. 462
8.7 EDWARDS LIFESCIENCES CORP. 467
8.8 JOHNSON & JOHNSON (BIOSENSE WEBSTER) 476
8.9 MEDTRONIC PLC 483
8.10 TERUMO CORPORATION 495
8.11 W.L. GORE & ASSOCIATES, INC. 505
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Buy now using our secure payment system.